Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Megestrol Acetate 40 MG
DRUG
2 trials
Sponsors
Cambridge University Hospitals NHS Foundation Trust
, Women's Hospital School Of Medicine Zhejiang University
Conditions
Breast Cancer
Endometrial Cancer Stage I
Endometrial Hyperplasia
Phase 2
A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer
Completed
NCT03306472
Cambridge University Hospitals NHS Foundation Trust
Breast Cancer
Start: 2017-07-20
End: 2023-10-31
Updated: 2024-01-30
Unknown Phase
Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women
Recruiting
NCT06417736
Women's Hospital School Of Medicine Zhejiang University
Endometrial Cancer Stage I, Endometrial Hyperplasia
Start: 2023-12-01
End: 2026-12-31
Target: 75
Updated: 2024-05-16
Related Papers
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial.
2026-01-05